Injective (INJ) has surged 25% in 24 hours and over 70% in the past month, driven by strong spot and derivatives demand. The token's revenue-to-fully diluted value ratio is notably higher than competitors like Arbitrum and Ethereum, indicating solid network usage. A new partnership with Gulf Labs focusing on tokenization has further fueled bullish sentiment. Technical indicators suggest potential for continued upward momentum if key resistance levels are surpassed.
Injective (INJ) is up 26.38% on Pluang, trading at Rp163.540 with a market cap of Rp16,63T as of Oct 16, 2026 15:21 WIB. This strong performance contrasts with Arbitrum (ARB) and Ethereum (ETH), which are up 11.92% and 3.53% respectively on the same platform and time.
Injective (INJ) surged 27.8% to $9.27, leading Friday's crypto gainers while Bitcoin remained stable around $82,197. This sharp rise highlights growing investor interest in altcoins despite Bitcoin dominance holding steady at 59.3%. Market sentiment ...
Injective's token price surged over 8% on October 16, reaching $9.35, driven by increased trading volume and positive market sentiment from new institutional developments. Key factors include Gulf Labs joining as an institutional validator and ongoin...
Injective (INJ) surged 24.46% to $9.13 on October 16, 2026, driven by sustained token withdrawals from exchanges and a major institutional data migration by Pineapple Financial. Despite high reported trading volumes, much of the on-chain activity is ...
Akedo (AKE) surged 16.09% to $0.0316, driven by growing investor interest in gaming-related crypto projects, pushing its market cap to $719.91 million. Meanwhile, Bitway (BTW) dropped sharply by 23.10% to $1.81 amid regulatory concerns, highlighting ...
Injective (INJ) fell 10.07% within 24 hours to $7.29 after briefly rising above $8 but failing to maintain that level, indicating a failed breakout. The price slipped below key pivot and short-term moving averages, signaling potential weakness. Open ...
